Yusuke Takinami

YF476 is a new potent and selective gastrin/cholecystokinin‐B receptor antagonist <i>in vitro</i> and <i>in vivo</i>

Yusuke Takinami, Hidenobu Yuki, Akito Nishida et al. · Alimentary Pharmacology & Therapeutics · 1997 · 64 citations

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.

Akito Nishida, Yusuke Takinami, Hidenobu Yuki et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 52 citations

Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression

Akito Nishida, A. Kobayashi-Uchida, Shinobu Akuzawa et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1995 · 29 citations

Mucosal Protective Effect of Leminoprazole on Reflux Esophagitis Induced in Rats

Susumu Okabe, Yusuke Takinami, K Iwata et al. · The Japanese Journal of Pharmacology · 1995 · 18 citations · Full text

Reflux Esophagitis Induced, Anti-inflammatory Agents, Allergy +12

YM022, A Potent and Selective Gastrin/CCK-B Receptor Antagonist, Inhibits Peptone Meal-Induced Gastric Acid Secretion in Heidenhain Pouch Dogs

Hidenobu Yuki, Akito Nishida, Akira Miyake et al. · Digestive Diseases and Sciences · 1997 · 15 citations